SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells Journal Article


Authors: Mortera-Blanco, T.; Dimitriou, M.; Woll, P. S.; Karimi, M.; Elvarsdottir, E.; Conte, S.; Tobiasson, M.; Jansson, M.; Douagi, I.; Moarii, M.; Saft, L.; Papaemmanuil, E.; Jacobsen, S. E. W.; Hellström-Lindberg, E.
Article Title: SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells
Abstract: Mutations in the RNA splicing gene SF3B1 are found in >80% of patients with myelodysplastic syndrome with ring sideroblasts (MDS-RS). We investigated the origin of SF3B1 mutations within the bone marrow hematopoietic stem and progenitor cell compartments in patients with MDS-RS. Screening for recurrently mutated genes in the mononuclear cell fraction revealed mutations in SF3B1 in 39 of 40 cases (97.5%), combined with TET2 and DNMT3A in 11 (28%) and 6 (15%) patients, respectively. All recurrent mutations identified in mononuclear cells could be tracked back to the phenotypically defined hematopoietic stem cell (HSC) compartment in all investigated patients and were also present in downstream myeloid and erythroid progenitor cells. While in agreement with previous studies, little or no evidence for clonal (SF3B1 mutation) involvement could be found in mature B cells, consistent involvement at the pro–B-cell progenitor stage was established, providing definitive evidence for SF3B1 mutations targeting lymphomyeloid HSCs and compatible with mutated SF3B1 negatively affecting lymphoid development. Assessment of stem cell function in vitro as well as in vivo established that only HSCs and not investigated progenitor populations could propagate the SF3B1 mutated clone. Upon transplantation into immune-deficient mice, SF3B1 mutated MDS-RS HSCs differentiated into characteristic ring sideroblasts, the hallmark of MDS-RS. Our findings provide evidence of a multipotent lymphomyeloid HSC origin of SF3B1 mutations in MDS-RS patients and provide a novel in vivo platform for mechanistically and therapeutically exploring SF3B1 mutated MDS-RS. © 2017 by The American Society of Hematology.
Journal Title: Blood
Volume: 130
Issue: 7
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-08-17
Start Page: 881
End Page: 890
Language: English
DOI: 10.1182/blood-2017-03-776070
PROVIDER: scopus
PUBMED: 28634182
PMCID: PMC5572789
DOI/URL:
Notes: Article -- Export Date: 5 September 2017 -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Matahi Wilfrid Serge Moarii
    7 Moarii